chr15-39934255-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 2P and 11B. PM2BP4_ModerateBP6_Very_StrongBP7
The NM_001013703.4(EIF2AK4):c.60G>A(p.Pro20=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000184 in 1,610,190 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.00012 ( 0 hom., cov: 33)
Exomes 𝑓: 0.00019 ( 0 hom. )
Consequence
EIF2AK4
NM_001013703.4 synonymous
NM_001013703.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.301
Genes affected
EIF2AK4 (HGNC:19687): (eukaryotic translation initiation factor 2 alpha kinase 4) This gene encodes a member of a family of kinases that phosphorylate the alpha subunit of eukaryotic translation initiation factor-2 (EIF2), resulting in the downregulaton of protein synthesis. The encoded protein responds to amino acid deprivation by binding uncharged transfer RNAs. It may also be activated by glucose deprivation and viral infection. Mutations in this gene have been found in individuals suffering from autosomal recessive pulmonary venoocclusive-disease-2. [provided by RefSeq, Mar 2014]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -9 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.39).
BP6
Variant 15-39934255-G-A is Benign according to our data. Variant chr15-39934255-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 618617.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.301 with no splicing effect.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
EIF2AK4 | NM_001013703.4 | c.60G>A | p.Pro20= | synonymous_variant | 1/39 | ENST00000263791.10 | NP_001013725.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
EIF2AK4 | ENST00000263791.10 | c.60G>A | p.Pro20= | synonymous_variant | 1/39 | 2 | NM_001013703.4 | ENSP00000263791 | P1 | |
EIF2AK4 | ENST00000559624.5 | c.60G>A | p.Pro20= | synonymous_variant | 1/11 | 1 | ENSP00000453148 | |||
EIF2AK4 | ENST00000560648.1 | c.60G>A | p.Pro20= | synonymous_variant | 1/4 | 3 | ENSP00000453968 |
Frequencies
GnomAD3 genomes AF: 0.000118 AC: 18AN: 152138Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
18
AN:
152138
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000550 AC: 13AN: 236434Hom.: 0 AF XY: 0.0000540 AC XY: 7AN XY: 129734
GnomAD3 exomes
AF:
AC:
13
AN:
236434
Hom.:
AF XY:
AC XY:
7
AN XY:
129734
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000191 AC: 278AN: 1458052Hom.: 0 Cov.: 29 AF XY: 0.000153 AC XY: 111AN XY: 725216
GnomAD4 exome
AF:
AC:
278
AN:
1458052
Hom.:
Cov.:
29
AF XY:
AC XY:
111
AN XY:
725216
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000118 AC: 18AN: 152138Hom.: 0 Cov.: 33 AF XY: 0.000135 AC XY: 10AN XY: 74330
GnomAD4 genome
AF:
AC:
18
AN:
152138
Hom.:
Cov.:
33
AF XY:
AC XY:
10
AN XY:
74330
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Likely benign, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Dec 17, 2017 | The c.60G>A variant has not been reported in the medical literature, gene specific variation databases, nor has it been previously identified by our laboratory. It is present in the genome Aggregation Database with an overall population frequency of 0.006% (15 out of 264,584 chromosomes). The guanine in exon 20 is not highly conserved, and the variant is not predicted to alter EIF2AK4 mRNA splicing (Alamut software v.2.10.0). Therefore, the c.60G>A variant is likely to be benign. - |
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | May 08, 2018 | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at